Trending News
News
News
Thermo Fisher Scientific Acquires nAscent BioSciences
The nAscent product lines, which include the PocketTip® pipette tip, will be integrated into Thermo Fisher Scientific’s existing liquid handling consumables business.
News
ApoCell to Conduct Studies in Support of Pfizer Cancer Drug Trial
ApoCell will use its TEP™ technology to generate data to select patients most likely to benefit from the drug and to quantify the pharmacodynamic activity of the new drug.
News
Cigarettes Destroy Gene that Fights Aging
A University of Rochester scientist said toxins in cigarette smoke wipe out a gene that plays a vital role in protecting against premature aging.
News
In Diatom, Scientists Find Genes that may Level Engineering Hurdle
A team led by professor of the University of Washington has reported finding a set of 75 genes specifically involved in silica bioprocessing in the diatom.
News
IPSOGEN Licenses the Genomic Grade™ to Improve Breast Cancer Diagnosis & Treatment Decision
IPSOGEN signed a license agreement with Universite Libre de Bruxelles (ULB), Belgium for the worldwide and exclusive rights on the Genomic Grade™.
News
LabCorp Announces Definitive Agreement to Acquire Tandem Labs
Tandem Labs will continue to operate under its existing name with its current employee and management structure, as a member of the Esoterix clinical trials group at LabCorp.
News
Several Genes that Regulate the Disease SLE have been Identified
Uppsala researchers have identified a number of new genes that can be tied to the disease SLE, including a gene that hopefully might be used to treat the disease.
News
TransTech Pharma Acquires Three Programs for the Treatment of Metabolic Disorder from Novo Nordisk
TransTech has acquired all rights from Novo Nordisk to a portfolio of drug candidates being developed to treat metabolic disorders.
News
BioMS Medical Completes Licensing Deal with Lilly
As part of the agreement, BioMS has received an upfront cash payment of US$87 million.
News
StemCells, Inc. Enters Research Collaboration with Casey Eye Institute
The collaboration aims to evaluate the StemCells Inc.’s HuCNS-SC ® product candidate as a potential treatment for retinal degeneration.
Advertisement